secwatch / observer
8-K filed May 29, 2024, 7:59 PM ET ticker DCTH CIK 0000872912
other confidence high sentiment neutral materiality 0.55

Delcath Systems appoints Bridget Martell to board; faces Nasdaq audit committee non-compliance

DELCATH SYSTEMS, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Bridget Martell

Class III Director
DCTH · DELCATH SYSTEMS, INC.
Effective
2024-05-23
Filed
May 29, 2024, 7:59 PM ET
on May 23, 2024, the Company appointed Bridget Martell, M.A. M.D., as a Class III Director on the Company's Board, commencing on May 23, 2024
Departed

Roger Stoll

Director
DCTH · DELCATH SYSTEMS, INC.
Effective
2024-05-23
Successor
Bridget Martell
Filed
May 29, 2024, 7:59 PM ET
Following the voting on Proposal 1 (as listed below in Item 5.07) at the Annual Meeting on May 23, 2024, Roger Stoll's previously announced retirement from the Board took effect.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bridget Martell was appointed as Class III Director at DELCATH SYSTEMS, INC..

Action
appointed
Role
Class III Director
Exact text from the filing
on May 23, 2024, the Company appointed Bridget Martell, M.A. M.D., as a Class III Director on the Company's Board, commencing on May 23, 2024
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Roger Stoll retired as Director at DELCATH SYSTEMS, INC..

Action
retired
Role
Director
Exact text from the filing
Following the voting on Proposal 1 (as listed below in Item 5.07) at the Annual Meeting on May 23, 2024, Roger Stoll's previously announced retirement from the Board took effect.
View on SEC.gov

DELCATH SYSTEMS, INC. filing history →

Source: SEC EDGAR
accession 0001193125-24-149142
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.